1. Home
  2. NPV vs MDWD Comparison

NPV vs MDWD Comparison

Compare NPV & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Virginia Quality Municipal Income Fund

NPV

Nuveen Virginia Quality Municipal Income Fund

HOLD

Current Price

$9.60

Market Cap

184.3M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$12.04

Market Cap

162.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPV
MDWD
Founded
1993
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.3M
162.2M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
NPV
MDWD
Price
$9.60
$12.04
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $30.67
AVG Volume (30 Days)
★ 125.2K
79.3K
Earning Date
01-01-0001
11-19-2026
Dividend Yield
★ 3.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$39.60
Revenue Next Year
N/A
$34.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.05
$11.84
52 Week High
$11.81
$19.70

Technical Indicators

Market Signals
Indicator
NPV
MDWD
Relative Strength Index (RSI) 48.56 39.47
Support Level $9.05 $11.84
Resistance Level $11.61 $14.06
Average True Range (ATR) 0.15 0.50
MACD 0.07 -0.04
Stochastic Oscillator 67.86 11.54

Price Performance

Historical Comparison
NPV
MDWD

About NPV Nuveen Virginia Quality Municipal Income Fund

Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. The company mostly invests in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities, Housing/Multifamily, Transportation, and Others.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: